NKG2D.Zeta-NK cell conditioning
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NKG2D.Zeta-NK cell conditioning, covering 2026-02-06 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma [Phase 1]